Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives

Επιστημονική δημοσίευση - Άρθρο Περιοδικού
uoadl:3119645

Μονάδες

Ερευνητικό υλικό ΕΚΠΑ

Τίτλος

Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives

Γλώσσες Τεκμηρίου

Αγγλικά

Περίληψη

Purpose of Review: Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease with rising prevalence worldwide. Herein, we provide a comprehensive overview of the current knowledge supporting the role of ER stress and autophagy processes in NAFLD pathogenesis and progression. We also highlight the interrelation between these two pathways and the impact of ER stress and autophagy modulators on NAFLD treatment. Recent Findings: The pathophysiological mechanisms involved in NAFLD progression are currently under investigation. The endoplasmic reticulum (ER) stress and the concomitant unfolded protein response (UPR) seem to contribute to its pathogenesis mainly due to high ER content in the liver which exerts significant metabolic functions and can be dysregulated. Furthermore, disruption of autophagy processes has also been identified in NAFLD. The crucial role of these two pathways in NAFLD is underlined by the fact that they have recently emerged as promising targets of therapeutic interventions. Summary: There is a greater need for finding the natural/chemical compounds and drugs which can modulate the ER stress pathway and autophagy for the treatment of NAFLD. Clarifying the inter-relation between these two pathways and their interaction with inflammatory and apoptotic mechanisms will allow the development of additional therapeutic options which can better target and reprogram the underlying pathophysiological pathways, aiming to attenuate NAFLD progression. © 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Έτος δημοσίευσης

2021

Συγγραφείς

Flessa, C.-M. Kyrou, I. Nasiri-Ansari, N. Kaltsas, G. Papavassiliou, A.G. Kassi, E. Randeva, H.S.

Περιοδικό

null

Εκδότης

Springer-Verlag

Τόμος

10

Αριθμός / τεύχος

2

Σελίδες

134-161

Λέξεις-κλειδιά

acetyl coenzyme A carboxylase
activating transcription factor 4
activating transcription factor 6
activating transcription factor 6 alpha
adipocytokine
angiopoietin like 3
angiopoietin related protein
apolipoprotein B100
autophagy related protein
autophagy related protein 5
autophagy related protein 8 family
basic leucine zipper transcription factor
beclin 1
cantharidin
carboxylesterase
carboxylesterase 1
caveolin 1
CCAAT enhancer binding protein beta
CD40 ligand
corilagin
crocin
cryopyrin
cryptotanshinone
curcumin
diacylglycerol acyltransferase 2
diiodothyronine
dipeptidyl peptidase IV inhibitor
elongation factor 2
empagliflozin
epigallocatechin gallate
exendin 4
ezetimibe
farnesoid X receptor
fat droplet
gallic acid propyl ester
geniposide
glucagon like peptide 1
glucagon like peptide 1 receptor agonist
glucose regulated protein 78
growth arrest and DNA damage inducible protein 153
guanabenz
hypoxia inducible factor 1alpha
immunoglobulin enhancer binding protein
inositol
inositol requiring enzyme 1 alpha
liothyronine
lipoprotein receptor
liraglutide
liver enzyme
mammalian target of rapamycin
mammalian target of rapamycin complex 1
melatonin
metformin
microRNA 214
nuclear receptor DAX 1
nucleotide binding oligomerization domain like receptor
peretinoin
peroxisome proliferator activated receptor gamma
pioglitazone
proprotein convertase 9
protein tyrosine phosphatase
quercetin
resveratrol
rosiglitazone
salubrinal
selonsertib
sequestosome 1
serine threonine protein kinase ULK1
sirtuin 6
sodium glucose cotransporter 2
sterol regulatory element binding protein 2
stress activated protein kinase
tangeretin
taurursodiol
tetrahydrolipstatin
thioredoxin interacting protein
transcription factor FKHR
transcription factor FOXO
transcription factor Nrf2
transforming growth factor beta
unclassified drug
ursodeoxycholic acid
valosin containing protein
X box binding protein 1
adipose tissue
alanine aminotransferase level
apoptosis
aspartate aminotransferase level
autophagy (cellular)
body mass
cancer growth
disease exacerbation
endoplasmic reticulum stress
gamma glutamyl transferase blood level
homeostasis
human
hyperglycemia
hyperinsulinemia
inflammation
lipid diet
lipolysis
liver cell carcinoma
non insulin dependent diabetes mellitus
nonalcoholic fatty liver
nonalcoholic steatohepatitis
obesity
oxidative stress
pathogenesis
randomized controlled trial (topic)
Review
steatosis
unfolded protein response
animal
autophagy
endoplasmic reticulum stress
liver
metabolism
nonalcoholic fatty liver
pathology
physiology
Animals
Autophagy
Endoplasmic Reticulum Stress
Humans
Liver
Non-alcoholic Fatty Liver Disease
Obesity
Unfolded Protein Response

Τελευταία τροποποίηση

πριν από 3 έτη

Άδεια χρήσης

Creative Commons Αναφορά Δημιουργού-Μη Εμπορική Χρήση 4.0 (CC-BY-NC)

Εξαγωγή Citation

Ο ιστοχώρος χρησιμοποιεί cookies για να σας προσφέρει πιο πλούσια εμπειρία χρήσης. Εφόσον συνεχίσετε να τον χρησιμοποιείτε, αποδέχεστε και τη χρήση των cookies. Περισσότερες πληροφορίες: https://www.uoa.gr/to_panepistimio/prostasia_prosopikon_dedomenon/